Natural history of proteinuria in renal transplant recipients developing de novo human leukocyte antigen antibodies

Transplantation

Volumn 91, Issue 9, 2011, Pages 991-996

  Fotheringham, James ^a,d   Angel, Carole ^b   Goodwin, John ^c   Harmer, Andrea W ^c   McKane, William S ^a  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

HLA antibodies; Humoral rejection; Proteinuria; Renal transplantation

Indexed keywords

ALLOANTIBODY; AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; HLA ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSURVEILLANCE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; SURVIVAL TIME;

ADULT; ANTIBODY SPECIFICITY; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROTEINURIA; RENIN-ANGIOTENSIN SYSTEM; TISSUE DONORS;

EID: 79955531057     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182126ed0     Document Type: Article

References (27)

1. Terasaki PI, Ozawa M. Predicting kidney graft failure by HLA antibodies: A prospective trial. Am J Transplant 2004; 4: 438.
2. Pelletier RP, Hennessy PK,AdamsPW,et al. Clinical significance ofMHCreactive alloantibodies that develop after kidney or kidney-pancreas transplantation. Am J Transplant 2002; 2: 134.
3. Hourmant M, Cesbron-Gautier A, Terasaki PI, et al. Frequency and clinical implications of development of donor-specific and non-donorspecific HLA antibodies after kidney transplantation. J AmSoc Nephrol 2005; 16: 2804.
4. Worthington JE, Martin S, Al-Husseini DM, et al. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation 2003; 75: 1034.
5. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003; 3: 665.
6. Sis B, Campbell PM, Mueller T, et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007; 7: 1743.
7. KannelWB,Stampfer MJ, CastelliWP,et al. The prognostic significance of proteinuria: The Framingham study. Am Heart J 1984; 108: 1347.
8. Iseki K, Ikemiya Y, Iseki C, et al. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003; 63: 1468.
9. Hohage H, Kleyer U, Bruckner D, et al. Influence of proteinuria on long-term transplant survival in kidney transplant recipients. Nephron 1997; 75: 160.
10. Yildiz A, Erkoc R, Sever MS, et al. The prognostic importance of severity and type of post-transplant proteinuria. Clin Transplant 1999; 13: 241.
11. Fernandez-Fresnedo G, Plaza JJ, Sanchez-Plumed J, et al. Proteinuria: A new marker of long-term graft and patient survival in kidney transplantation. Nephrol Dial Transplant 2004; 19(Suppl 3): iii47.
12. Halimi JM, Laouad I, Buchler M, et al. Early low-grade proteinuria: Causes, short-term evolution and long-term consequences in renal transplantation. Am J Transplant 2005; 5: 2281.
13. Peddi VR, Dean DE, Hariharan S, et al. Proteinuria following renal transplantation: Correlation with histopathology and outcome. Transplant Proc 1997; 29: 101.
14. First MR, Vaidya PN, Maryniak RK, et al. Proteinuria following transplantation. Correlation with histopathology and outcome. Transplantation 1984; 38: 607.
15. Perez Fontan M, Rodriguez-Carmona A, Garcia Falcon T, et al. Early proteinuria in renal transplant recipients treated with cyclosporin. Transplantation 1999; 67: 561.
16. Gloor JM, Sethi S, Stegall MD, et al. Transplant glomerulopathy: Subclinical incidence and association with alloantibody. Am J Transplant 2007; 7: 2124.
17. Howell WM, Harmer A, Briggs D, et al. British Society for Histocompatibility & Immunogenetics and British Transplantation Society guidelines for the detection and characterisation of clinically relevant antibodies in allotransplantation. Int J Immunogenet 2010; 37: 435.
18. El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9: 527.
19. Gibney EM, Cagle LR, Freed B, et al. Detection of donor-specific antibodies using HLA-coated microspheres: Another tool for kidney transplant risk stratification. Nephrol Dial Transplant 2006; 21: 2625.
20. Karpinski M, Rush D, Jeffery J, et al. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol 2001; 12: 2807.
21. Gill JS, Landsberg D, Johnston O, et al. Screening for de novo antihuman leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection. Transplantation 2010; 89: 178.
22. Campos EF, Tedesco-Silva H, Machado PG, et al. Post-transplant anti- HLA class II antibodies as risk factor for late kidney allograft failure. Am J Transplant 2006; 6: 2316.
23. Cosio FG, Gloor JM, Sethi S, et al. Transplant glomerulopathy. Am J Transplant 2008; 8: 492.
24. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753.
25. Hiremath S, Fergusson D, Doucette S, et al. Renin angiotensin system blockade in kidney transplantation: A systematic review of the evidence. Am J Transplant 2007; 7: 2350.
26. Bray RA, Gebel HM. Strategies for human leukocyte antigen antibody detection. Curr Opin Organ Transplant 2009; 14: 392.
27. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461